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YisP is involved in biofilm formation in Bacillus
subtilis and has been predicted to produce C30
isoprenoids. We determined the structure of YisP
and observed that it adopts the same fold as
squalene and dehydrosqualene synthases. How-
ever, the first aspartate-rich motif found in essen-
tially all isoprenoid synthases is aspartate poor in
YisP and cannot catalyze head-to-head condensa-
tion reactions. We find that YisP acts as a phos-
phatase, catalyzing formation of farnesol from
farnesyl diphosphate, and that it is the first phos-
phatase to adopt the fold seen in the head-to-
head prenyl synthases. Farnesol restores biofilm
formation in a Dyisp mutant and modifies lipid
membrane structure similarly to the virulence factor
staphyloxanthin. This work clarifies the role of YisP
in biofilm formation and suggests an intriguing pos-
sibility that many of the YisP-like homologs found in
other bacteria may also have interesting products
and functions.
INTRODUCTION
There is currently considerable interest in the structure, function,
and inhibition of the enzymes involved in isoprenoid biosynthesis
since, in many instances, these enzymes represent new drug tar-
gets (Oldfield, 2010; Oldfield and Lin, 2012). One such class of
molecules catalyze the ‘‘head-to-head’’ condensation of isopre-
noid diphosphates to form triterpenes such as squalene and
dehydrosqualene, reactions catalyzed by squalene synthase
(SQS) and dehydrosqualene synthase (CrtM, in Staphylococcus
aureus), respectively (Figure 1). Inhibition of SQS is of interest in
the context of the development of cholesterol-lowering drugs
(Kourounakis et al., 2011) and of antiparasitics targeting ergos-Chemistry & Biology 21, 1557–156terol biosynthesis (Shang et al., 2014; Urbina, 2009), while
CrtM is of interest because in S. aureus, it is involved in formation
of staphyloxanthin (Pelz et al., 2005; Wieland et al., 1994), a viru-
lence factor for the organism providing resistance to killing from
host reactive oxygen species (Clauditz et al., 2006; Liu et al.,
2005). Interestingly, staphyloxanthin levels are elevated in
S. aureus biofilms (Resch et al., 2005), and the CrtM inhibitor zar-
agozic acid (Figure 1B) inhibits biofilm formation by affecting lipid
microdomain (‘‘raft’’) organization (Lo´pez and Kolter, 2010). An
effect of staphyloxanthin on bacterial membrane structure
(order) has been shown via fluorescence depolarization (of a
1,3,5-diphenylhexatriene probe), and cells with elevated staphy-
loxanthin level are more rigid and more resistant to the mem-
brane-targeting antibiotic daptomycin (Mishra et al., 2011).
A close analog of the crtM gene (yisP) is also present inBacillus
subtilis, and it was recently reported (Lo´pez and Kolter, 2010)
that YisP was involved in biofilm and pigment formation in
B. subtilis and had SQS activity. To learn more about the struc-
ture and function of YisP, we have solved its structure by X-ray
crystallography and determined the structure of the product
formed by YisP from farnesyl diphosphate (FPP), as well as its
effect on biofilm formation, in B. subtilis.
The BsYisP sequence is shown in the alignment in Figure 2,
and it appears on initial inspection to contain the two expected
‘‘aspartate-rich’’ (DDXXD/E and DXXXD) domains (Christianson,
2006) found in many prenyl transferases, with a DDLDE and
DLGTD motif being found in the sequence. However, as can
be seen in the alignment of YisP, CrtM, and SQS in Figure 2,
there are some puzzling features. First, the region of the first
aspartate-rich motif (FARM) seen in the alignments of many
prenyl synthases, in YisP, is aspartate poor: AASAD. Second,
the DDLDE motif is actually between the FARM and second
aspartate-rich motif (SARM) found in human SQS (HsSQS) and
CrtM. These results suggest either that YisP might not make
squalene (or dehydrosqualene), because a DDXXD motif in the
FARM region is expected to be involved in Mg2+ binding and
allylic diphosphate ionization to initiate catalysis, or that it
has an unusual fold that is not suggested by the sequence
alignments.3, November 20, 2014 ª2014 Elsevier Ltd All rights reserved 1557
Figure 1. Structures of Compounds of Interest
(A) Biosynthesis of virulence factors, sterols, and farnesol.
(B) A biofilm inhibitor and some B. subtilis pigments.
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The Structure of B. subtilis YisP
In recent work (Hu et al., 2013) we cloned, expressed, purified,
crystallized, and obtained diffraction data on B. subtilis YisP.
The crystals belonged to the orthorhombic space group
P212121 with unit-cell parameters a = 43.966 A˚, b = 77.576 A˚,
c = 91.378 A˚, and diffracted to 1.92 A˚. Here, we solved the
YisP structure by using two Hg-containing derivatives (BsYisP
has only 23% sequence identity with S. aureus CrtM, and the
structure could not be solved by molecular replacement). Full
data collection and refinement statistics are given in Table S1
(available online). We obtained one structure (Figure 3) with a
molecule bound in the active site region, most likely a polyeth-
ylene glycol (PEG) from the crystallization buffer and not a bound
substrate or product isoprenoid, because as can be seen in the
electron density (Figure S1), there are nomethyl substituents and
no planar groups. Numerous attempts to obtain structures of
YisP with FPP, S-thiolo-FPP, S-thiolo-geranylgeranyl diphos-
phate (GGPP), or farnesol ligands were unsuccessful.
The YisPmolecule adopts the ε-fold as do CrtM and SQS (Fig-
ure 3A), but the DDLDEmotif is located some 20 A˚ outside of the
active site region found in theCrtMandSQSstructures (Figure 4),
while the AASAD motif superimposes on the first aspartate-rich
motif found in these proteins, as does the second aspartate-
rich motif. A possible implication of these results is that YisP
might not function as a head-to-head prenyl synthase since1558 Chemistry & Biology 21, 1557–1563, November 20, 2014 ª2014the first aspartate residue found in CrtM and SQS is actually an
alanine in YisP, and the DDLDE motif is well outside the active
site region found in CrtM and SQS. There is one main pocket
in the YisP structure, with a total volume (calculated using
PocketFinder [Hendlich et al., 1997]) of 1,000 A˚3. This pocket
(Figure 3A, black mesh) is occupied by the single PEG molecule
(Figure 3B), which is located in the S2 (prenyl donor) site identi-
fied previously in CrtM and SQS (Liu et al., 2008). Notably, this
pocket volume is much smaller than that found in CrtM protein
structures (1,600 A˚3, on average; Figure 4A) or HsSQS
(1,900 A˚3, on average; Figure 4B), suggesting the possibility
that the YisP product might be smaller than the C30 species pro-
duced by CrtM and SQS.
The Nature of YisP Activity: YisP Is a Phosphatase
We next sought evidence for formation of any head-to-head
(squalene or squalene-like) condensation products since only
phosphate release was detected in earlier work (Lo´pez and Kol-
ter, 2010). We carried out reactions with many combinations of
diphosphates (including isopentenyl diphosphate [IPP], dime-
thylallyl diphosphate [DMAPP], geranyl diphosphate [GPP],
FPP and GGPP) with Mg2+ or Mn2+ in the presence or absence
of NADH or NADPH, but we found no evidence for condensation
products (by radio-thin-layer chromatography [TLC] or by gas
chromatography-mass spectrometry) under conditions where
large amounts of squalene or dehydrosqualene were readily
detected with SQS or CrtM. We also used several differentElsevier Ltd All rights reserved
Figure 2. ClustalW Alignment of BsYisP,
SaCrtM, and HsSQS Showing First and
Second Aspartate-Rich Domains and the
DDLDE Domain in BsYisP
Chemistry & Biology
Structure and Function of Bacillus subtilis YisPdetergents (Triton X-100, Tween 80, and IGEPAL), but we were
again unable to detect any squalene or dehydrosqualene (or
related) products. Nevertheless, consistent with earlier work,
we did find that there was phosphate release using the preferred
substrate (Lo´pez and Kolter, 2010), FPP, as a substrate, but the
reaction rate was only minimally affected by NADH or NADPH
(Figure 5A). The product was, however, the sesquiterpene
alcohol farnesol, as determined by radio-TLC using [14C]FPP
(produced from GPP and [14C]IPP; Figure 5B). FPP reacted 2.5
times faster than did GPP and six times faster than did DMAPP,
and GGPP was not active, in accord with results reported previ-
ously (Lo´pez and Kolter, 2010). These results suggest that YisP
may act as a phosphatase, not as a prenyl synthase.
Site-directed mutagenesis results showed that mutation of
A54 and A55 in the AASAD motif to aspartate had only a small
effect on phosphate-release activity (Figure S2), and again no
condensation products were formed. However, D58A, D167A,
and D171A mutants had only background levels of activity, Fig-
ure S2, indicating a role in catalysis. These results are consistent
with the X-ray crystallographic result that the DDLDE motif is not
in the active site region seen in CrtM or SQS, and the first
aspartate in the DXXXD first aspartate-rich motif found in CrtM
and SQS in YisP is an alanine. Mutations at this position in
SQS are known to abrogate activity and in SQS, this aspartate
is very highly conserved (Gu et al., 1998; Lin et al., 2010).
Therefore, YisP adopts the ε-fold seen in SQS and CrtM but
acts as a phosphatase, raising the question as to the origin of
the pigmentation reported earlier (Lo´pez and Kolter, 2010), in
addition to the question of whether the YisP product effects
biofilm formation.
B. subtilis Pigmentation
B. subtilis was reported in very early literature to not produce
carotenoids (Clejan et al., 1986), consistent with our observation
that YisP—the only head-to-head prenyl synthase-like enzyme in
the B. subtilis genome—is a phosphatase. In S. aureus, the gene
with direct homology to YisP is CrtM, which catalyzes formation
of dehydrosqualene. CrtM is part of an operon—CrtMNOPQ—
and the final product of this pathway is the bright orange carot-
enoid pigment, the virulence factor staphyloxanthin. However, in
B. subtilis, it does not appear that yisP is part of an operon
involved in carotenoid biosynthesis, with the adjacent genes be-
ing yisA (a DinB family, damage-inducible gene), yisQ (Norm, an
Na+-driven multidrug efflux pump), and yisR (an Arac family
translational regulator). The issue is, then, the nature of the
pigmentation seen in B. subtilis. As can be seen in Figure 5C,Chemistry & Biology 21, 1557–1563, November 20, 2014 ªthe UV-Vis spectra of both wild-type
(WT) and a DyisP mutant strain of
B. subtilis (at pH 7) are dominated by a
broad peak with a lmax of 490 nm as
well as a peak at 390 nm. The 490 nm
peak is responsible for the dark red color-ation of the cells (Figure 5C) and in previous work has been
shown to arise from the complex formed between Fe3+ and pul-
cherriminic acid (Canale-Parola, 1963; Kupfer et al., 1967; Uffen
and Canale-Parola, 1972) (Figure 1). The pigment was first iden-
tified in the yeast Candida pulcherrima and later in B. subtilis
(Kluyver et al., 1953). On addition of base, the complex dissoci-
ates and sodium pulcherriminate (Figure 1) forms, with a lmax =
410 nm (Kupfer et al., 1967). We thus find no evidence for squa-
lene- or polyene-derived carotenoid pigments in B. subtilis, so
earlier conclusions (Lo´pez and Kolter, 2010) are hereby revised.
The Role of the YisP Product in Biofilm Formation and Its
Effects on Lipid Bilayer Structure
We next investigated the possible effects of the YisP product de-
tected here, farnesol, on B. subtilis biofilm formation. We used
the DyisP mutant, which is unable to form biofilms and whose
construction was reported earlier (Lo´pez and Kolter, 2010), and
as shown in Figure 6A, upon addition of farnesol, biofilm forma-
tion (on solid agar) is clearly visible (at right) in the DyisPmutant.
Similar results were obtained in MSgg culture (Figure 6B) at 4 mM
farnesol, and there were no effects on WT biofilm formation.
The issue then arises as to the likely role of farnesol in biofilm
formation. In previous work, an important role for lipid microdo-
mains in biofilm formation in B. subtilis (as well as S. aureus) was
demonstrated (Lo´pez and Kolter, 2010), so we hypothesized that
farnesol might be involved since it is well known to affect lipid
bilayer structure, as shown by both differential scanning calorim-
etry (DSC) and by solid-state deuterium nuclear magnetic reso-
nance spectroscopy (Bondar et al., 1994; Funari et al., 2005;
Rowat andDavis, 2004; Rowat et al., 2005). Specifically, farnesol
shifts and broadens phospholipid gel-to-liquid crystal phase
transitions and decreases DH, as does cholesterol (Ladbrooke
et al., 1968; Oldfield and Chapman, 1972), and is involved in lipid
microdomain (or raft) structures in eukaryotes, as illustrated
in Figure 7A with 1,2-dihexadecanoyl-sn-glycerophosphoryl
choline (DPPC). Interestingly, we find that staphyloxanthin also
shifts and broadens the gel-to-liquid crystal phase transition
and decreases DH (Figure 7A). The polyene in staphyloxanthin
cannot be readily ‘‘bent,’’ due to the presence of nine conjugated
double bonds, in which case the molecule will act as a rigid body
in the lipid bilayer (as does cholesterol) and its long/short side-
chain structure suggests it may form an interdigitated structure
(Figure 7B). This rigidifying effect of staphyloxanthin has been
proposed (based on diphenylhexatriene fluorescence depolari-
zation results) to ‘‘subvert non-oxidative host defensesmediated
by cationic peptides’’ (Mishra et al., 2011) and could also block2014 Elsevier Ltd All rights reserved 1559
Figure 4. Crystal Structures of CrtM and SQS
(A) CrtM liganded structure (PDB ID code 3ADZ) showing (canonical)
1,600 A˚3 pocket for S1+S2. The FARM and SARM are both conserved in the
head-to-head prenyl synthases.
(B) HsSQS structure (PDB ID code 3LEE) showing larger pocket volume
(1,900 A˚3, on average) due to the need for NADPH to bind in SQS, but not
CrtM. The smaller pocket in YisP suggests a smaller product than those
produced by CrtM or SQS.
Figure 3. YisP Structures
(A) Stereo view of X-ray structure of YisP (Protein Data Bank [PDB] ID code
3WE9) showing the conserved SARM, the DDLED domain, and the 1,000 A˚3
pocket.
(B) As in (A) but zoomed in to show the PEG ligand in S2, the SARM, and the
location of the missing FARM. Structure superimposed on the two S-thiolo-
FPP bound toCrtM (PDB ID code 2ZCP) showing PEGbound to YisP in S2 site.
See also Figure S1 for electron density of the PEG ligand.
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lence effect—and changes in lipid microdomain structure also
affect biofilm formation (Lo´pez and Kolter, 2010).
SIGNIFICANCE
We report the X-ray structure of YisP from B. subtilis,
known to be involved in biofilm formation. The fold is
similar to that seen in S. aureus CrtM and HsSQS, but
YisP acts as a phosphatase. There are two ‘‘DDXXD’’-like
motifs, as found in many prenyl synthases, but one motif
is 20 A˚ from the active site seen in SQS and CrtM. The
first ‘‘aspartate-rich’’ motif found in these prenyl synthases
is also aspartate poor in YisP (AASAD), so YisP is unable
to catalyze the head-to-head condensation of isoprenoid
diphosphates (to form species such as dehydrosqualene
or squalene), and no such products were obtained. The
only product found was farnesol, meaning that YisP can
act as a phosphatase, and we found that farnesol restored
biofilm formation in a Dyisp mutant under both solid agar
and liquid medium (MSgg) growth conditions. The lack of
any polyene or carotenoid pigments in B. subtilis is consis-
tent with the absence of CrtM-like activity in YisP and the
X-ray structure, and the pink or reddish coloration seen
(in both WT and the Dyisp mutant) is due to the presence
of the iron-containing pigment pulcherrimin. Overall, the re-
sults are significant because they help clarify the role of
YisP in biofilm formation in B. subtilis. In addition, since
there are also many other bacteria that harbor CrtM- or1560 Chemistry & Biology 21, 1557–1563, November 20, 2014 ª2014YisP-like homologs (based on sequence analyses and
structure predictions), based on the results presented
here and with S. aureus it seems likely that many of these
bacteria will also have interesting products and functions
since some of these organisms (e.g., Mycobacterium
tuberculosis) do not produce carotenoids (or sterols), so
the role of their CrtM- or YisP-like proteins remains to be
discovered.
EXPERIMENTAL PROCEDURES
Crystallization and Data Collection for BsYisP
BsYisP was cloned, expressed, and purified as described previously (Hu et al.,
2013). WT BsYisP was first crystallized by using the Grid Screen PEG/LiCl
screen kit (Hampton Research) and the sitting-drop vapor diffusion method.
The reservoir solution (no. C6) contained 1 M LiCl, 0.1 M bicine (pH 9), and
20% w/v PEG 6000. Better crystals were obtained by optimizing the crystalli-
zation condition to 1 M LiCl, 0.1 M bicine (pH 9), and 18%–20%w/v PEG 6000
at 25C for 2 days. To prepare heavy-atom derivatives, the Hg-containing re-
agents of Heavy Atom Screen Hg (Hampton Research) were used. Cryopro-
tectant solutions (1 M LiCl, 0.1 M bicine [pH 9], 20% w/v PEG 6000, and
10% glycerol) containing 2 mM Hg derivatives were used for soaking the WT
crystals for about 1 hr.
The X-ray diffraction data sets were collected at beamlines BL13B1 of the
National Synchrotron Radiation Research Center (NSRRC) and processed
by using the HKL2000 program (Otwinowski and Minor, 1997). Prior to struc-
tural refinement, 5% randomly selected reflections were set aside for calcu-
lating Rfree as a monitor. The multiple isomorphous replacement (MIR)
data sets of Hg-containing derivatives were collected at a wavelength of
0.97622 A˚ (BL13B1). Combination of data sets from different Hg-derivative
crystals with the ‘‘native’’ data set from the WT crystal using SOLVE and
RESOLVE (Adams et al., 2010) improved the figure of merit values from 0.24
to 0.41, the Z scores from 8.56 to 18.51, and the number of autobuilt amino
acid residues up to 177. The best results were obtained using mersalyl acid
and mercuric acetate derivatives. Statistics of the two Hg-derivative data
sets and the MIR phasing are summarized in Table S1. The model and map
were further improved by computational refinement using Refmac5 (Murshu-
dov et al., 1997). Finally, a complete model (but missing residues 57–81)
with most side chains was built using ARP/wARP (Langer et al., 2008). Struc-
tural refinements were carried out using CNS (Emsley and Cowtan, 2004) and
Coot (Bru¨nger et al., 1998). Data collection and refinement statistics are sum-
marized in Table S1. All diagrams of protein structures were prepared by using
PyMol (http://www.pymol.org/).Elsevier Ltd All rights reserved
Figure 6. Biofilm Formation in B. subtilis
(A) Biofilm formation on solid agar requires the production of an extracellular
matrix, which is correlated with the amount of wrinkles observed in the colony
(Lo´pez and Kolter, 2010). Treatment of the plate with a 10 ml drop of 500 mM
farnesol restores biofilm formation in the DyisP mutant.
(B) Biofilm formation in B. subtilis WT and DyisP mutant, in the presence or
absence of 4 mM farnesol.
Figure 5. YisP Activity and Pigment Formation
(A) NADPH or NADH shows little effect on kcat of YisP. Data are expressed as
average ± SD of two independent experiments.
(B) FPP is converted to farnesol by YisP but to squalene by SQS in the
presence of NADPH. The top trace is the control ([14C]FPP, no YisP). PAP,
potato acid phosphatase. See also Figure S2 for activities of WT and
mutant YisPs.
(C) UV-Vis of B. subtilis. Cells produced a dark pink pigment (pulcherrimin,
black lines). Upon addition of base the complex dissociates and sodium pul-
cherriminate forms (blue lines). WT cells are shown with solid lines, and DyisP
mutant cells are shown with broken lines.
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The mutants were prepared with a BsYisP–pET32 Xa/LIC vector as the
template, and the following forward primers were used: 50-GTATTG
TCGTTTTGCCACACGGATGCCAGTGCAGACGAAAAGGTA-30 for A54D,
50-TGCCACACGGCGGCCAGTGCAGCGGAAAAGGTATTGCCCGCATTT0 for
D58A, 50-CAGCTGGTTCGCTTCTTAAGTGCGCTTGGCACAGATCAGCAA
AAA-30 for D167A, 50-TTCTTAAGTGATCTTGGCACAGCGCAGCAAAAAAAC
CGCATTCCC-30 for D171A, and 50-TTGTCGTTTTGCCACACGGATGATAG
TGCAGACGAAAAGGTATTG-30 for A54D/A55D. The recombinant plasmids
were transformed to Escherichia coli BL21 trxB (DE3), and proteins were ex-
pressed and purified as for WT BsYisP (Hu et al., 2013).Chemistry & Biology 21, 1557–156BsYisP and HsSQS Activity Assay and Product Determination
The reaction of FPP catalyzed by BsYisP was monitored at 360 nm by using a
continuous spectrophotometric assay (Webb, 1992) for diphosphate release in
96-well plates with 200 ml reaction mixtures containing 400 mM 7-methyl-6-thi-
oguanosine, 0.1 U/ml purine nucleoside phosphorylase, and inorganic diphos-
phatase, 100 mM FPP, 100 mM NADPH or NADH, 25 mM Tris-HCl (pH 7.5),
0.2% detergent, and 1 mM MgCl2. Detergents tested were Triton X-100,
Tween 80, and IGEPAL, with IGEPAL giving the best activity.
Product identification of BsYisP and HsSQS was carried out using radio-
TLC with 14C-labeled FPP as substrate. The 14C-labeled FPP was synthesized
by adding 100 mM GPP, 100 mM [14C]IPP, and 1 mM human farnesyl diphos-
phate synthase to 50 ml of 25 mM Tris-HCl (pH 7.5), 0.2% detergent, and
1 mM MgCl2, and reacting at 37
C for 30 min. BsYisP or HsSQS (and
100 mM NADPH) was then added, and the resulting reaction mixture was
incubated at 37C for 2 hr. The reactions were then terminated by adding
500 ml of NaCl-saturated H2O, and the product was extracted with n-hexane.
The n-hexane solution was then concentrated and spotted onto a C183, November 20, 2014 ª2014 Elsevier Ltd All rights reserved 1561
Figure 7. Effects of Virulence Factor and
Raft Modulators on Lipid Bilayers
(A) DSC thermograms for DPPC (structure shown
in B) in the presence of 20 mol % additives. The
additives were farnesol (FOH), staphyloxanthin
(STX), and cholesterol (CHOL). The numbers in
parentheses are the DH for the main gel-to-liquid
crystal phase transitions (in kcal/mole). Samples
were in excess water.
(B) Cartoon showing proposed organization of
virulence factor/raft modulators in membranes.
The black stick DPPC structure serves as a ‘‘ruler’’
for CHOL, FOH, and STX. The orange cartoons
represent ordered or disordered DPPCmolecules.
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Structure and Function of Bacillus subtilis YisPreverse-phase TLC plate (Whatman). The TLC plate was developed with
acetone/methanol (2:8), and the product distribution was analyzed by using
a Storm 840 PhosphorImager and Quantity One (Bio-Rad).
Biofilm Formation Assay
Biofilm formation assays inB. subtiliswere carried out as described previously
(Lo´pez and Kolter, 2010).
DSC
DPPC was obtained from Avanti Polar Lipids. Farnesol and cholesterol were
obtained from Sigma-Aldrich. Staphyloxanthin was made as described previ-
ously (Nakano et al., 2011; Pelz et al., 2005); 20 mol % farnesol, cholesterol, or
staphyloxanthin was codissolved with DPPC in chloroform. The organic sol-
vent was removed under a stream of dry nitrogen, and the remaining solvent
traces were removed in vacuo, overnight. Ten microliters of deionized water
was added, and the mixtures were homogenized by hand. Weighed amounts
of the mixtures were then sealed into solid sample inserts (stainless steel
tubes). The DSC experiments were performed on a MicroCal VP-DSC instru-
ment. The scans covered the range from 10C to 60C at a scan rate of
90C/hr. The DSC thermograms were analyzed using Origin 7.1 (OrginLab).
Water versus water scans were used for baseline correction.
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